Florida Oncology and Hematology Relocates Fort Myers Clinic
Florida Oncology and Hematology Relocates Fort Myers Clinic
21 janv. 2025 08h00 HE | American Oncology Network
Florida Oncology and Hematology Relocates Fort Myers Clinic Local oncology practice moves to a new location.
Straits Logo 1-01 (1).png
Cancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits Research
20 janv. 2025 10h35 HE | Straits Research Private Limited - Garner Insights
New York, United States, Jan. 20, 2025 (GLOBE NEWSWIRE) -- A biopsy is a procedure where a small amount of tissue is extracted for examination under a microscope. In the case of a core biopsy,...
Straits Logo 1-01 (1).png
Drug Delivery Devices Market Size to Worth USD 482.69 Billion by 2033 | Straits Research
20 janv. 2025 09h35 HE | Straits Research Private Limited - Garner Insights
New York, United States, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Drug delivery refers to the methods, formulations, storage systems, manufacturing techniques, and technologies transporting a...
XXXX.png
Silexion Therapeutics Announces Pricing of $5.0 Million Public Offering
15 janv. 2025 20h00 HE | Silexion Therapeutics Corp
Cayman Islands, January 15, 2025 -- Silexion Therapeutics Corp (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for...
XXXX.png
Silexion Therapeutics Announces Additional Promising Preclinical Data for SIL-204, Demonstrating Impressive Synergy with First-Line Pancreatic Cancer Chemotherapies
15 janv. 2025 16h01 HE | Silexion Therapeutics Corp
Cayman Islands, January 15, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Logo_UCBC.jpg
University Cancer & Blood Center physicians recognized among Atlanta’s Top Doctors in Modern Luxury Medicine + Doctors magazine
15 janv. 2025 14h14 HE | University, Cancer and Blood Center
Four physicians from University Cancer & Blood Center are recognized as Top Doctors in Modern Luxury Medicine + Doctors magazine.
13180_AON_Charles-Goddard_Press-Release_Headshot_250110 (1)
American Oncology Network Appoints Charlie Goddard as General Counsel
15 janv. 2025 10h48 HE | American Oncology Network
American Oncology Network (AON) today announced the appointment of Charlie Goddard as General Counsel.
AIMLogo.jpg
AIM ImmunoTech Highlights Key 2024 Achievements and Outlines Upcoming 2025-26 Value-Driving Milestones
15 janv. 2025 09h05 HE | AIM ImmunoTech Inc.
– Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer and Long-COVID spaces –...
RAKOVINA Logo Mar2021.png
Rakovina Therapeutics Announces Key Milestone in Cancer Drug Innovation in Collaboration with Variational AI
13 janv. 2025 08h30 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel...
Data Update from Phase 2a Arm Evaluating IMM-1-104 with Modified FOLFIRINOX in First Line Pancreatic Cancer as of January 6, 2025
Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer
13 janv. 2025 08h00 HE | Immuneering Corporation
Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer